Contrast-Enhanced Mammography-Based Radiomics for Predicting Ductal Carcinoma In Situ in Breast Cancer
{{output}}
Our investigation focuses on developing and testing a radiomics nomogram based on contrast-enhanced mammography (CEM) and clinical factors to predict ductal carcinoma in situ (DCIS) in breast cancer. A retrospective analysis was performed on 731 breast cancer ... ...
